Asia-Pacific Coronary Drug-Eluting Stent Market Report 2017

  • KMI167834
  • Sep 2017
  • 122 pages
  • Medical Devices
In this report, the Asia-Pacific Coronary Drug-Eluting Stent market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Coronary Drug-Eluting Stent for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Coronary Drug-Eluting Stent market competition by top manufacturers/players, with Coronary Drug-Eluting Stent sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Boston Scientific
Cordis
Abbott
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Translumina
Vascular Concepts
JW Medical Systems
Kinhely
Lepu Medical
Medfavour Medical

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Durable Polymer Drug-eluting Stents
Bioabsorbable Polymer Drug-eluting Stent

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Coronary Drug-Eluting Stent for each application, includin
Coronary Heart Disease
Clinical

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Asia-Pacific Coronary Drug-Eluting Stent Market Report 2017
1 Coronary Drug-Eluting Stent Overview
1.1 Product Overview and Scope of Coronary Drug-Eluting Stent
1.2 Classification of Coronary Drug-Eluting Stent by Product Category
1.2.1 Asia-Pacific Coronary Drug-Eluting Stent Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Coronary Drug-Eluting Stent Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Durable Polymer Drug-eluting Stents
1.2.4 Bioabsorbable Polymer Drug-eluting Stent
1.3 Asia-Pacific Coronary Drug-Eluting Stent Market by Application/End Users
1.3.1 Asia-Pacific Coronary Drug-Eluting Stent Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Coronary Heart Disease
1.3.3 Clinical
1.4 Asia-Pacific Coronary Drug-Eluting Stent Market by Region
1.4.1 Asia-Pacific Coronary Drug-Eluting Stent Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Coronary Drug-Eluting Stent (2012-2022)
1.5.1 Asia-Pacific Coronary Drug-Eluting Stent Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Coronary Drug-Eluting Stent Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Coronary Drug-Eluting Stent Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Coronary Drug-Eluting Stent Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Coronary Drug-Eluting Stent Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Coronary Drug-Eluting Stent (Volume and Value) by Type
2.2.1 Asia-Pacific Coronary Drug-Eluting Stent Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Coronary Drug-Eluting Stent Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Coronary Drug-Eluting Stent (Volume) by Application
2.4 Asia-Pacific Coronary Drug-Eluting Stent (Volume and Value) by Region
2.4.1 Asia-Pacific Coronary Drug-Eluting Stent Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Coronary Drug-Eluting Stent Revenue and Market Share by Region (2012-2017)

3 China Coronary Drug-Eluting Stent (Volume, Value and Sales Price)
3.1 China Coronary Drug-Eluting Stent Sales and Value (2012-2017)
3.1.1 China Coronary Drug-Eluting Stent Sales Volume and Growth Rate (2012-2017)
3.1.2 China Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2017)
3.1.3 China Coronary Drug-Eluting Stent Sales Price Trend (2012-2017)
3.2 China Coronary Drug-Eluting Stent Sales Volume and Market Share by Type
3.3 China Coronary Drug-Eluting Stent Sales Volume and Market Share by Application

4 Japan Coronary Drug-Eluting Stent (Volume, Value and Sales Price)
4.1 Japan Coronary Drug-Eluting Stent Sales and Value (2012-2017)
4.1.1 Japan Coronary Drug-Eluting Stent Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2017)
4.1.3 Japan Coronary Drug-Eluting Stent Sales Price Trend (2012-2017)
4.2 Japan Coronary Drug-Eluting Stent Sales Volume and Market Share by Type
4.3 Japan Coronary Drug-Eluting Stent Sales Volume and Market Share by Application

5 South Korea Coronary Drug-Eluting Stent (Volume, Value and Sales Price)
5.1 South Korea Coronary Drug-Eluting Stent Sales and Value (2012-2017)
5.1.1 South Korea Coronary Drug-Eluting Stent Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Coronary Drug-Eluting Stent Sales Price Trend (2012-2017)
5.2 South Korea Coronary Drug-Eluting Stent Sales Volume and Market Share by Type
5.3 South Korea Coronary Drug-Eluting Stent Sales Volume and Market Share by Application

6 Taiwan Coronary Drug-Eluting Stent (Volume, Value and Sales Price)
6.1 Taiwan Coronary Drug-Eluting Stent Sales and Value (2012-2017)
6.1.1 Taiwan Coronary Drug-Eluting Stent Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Coronary Drug-Eluting Stent Sales Price Trend (2012-2017)
6.2 Taiwan Coronary Drug-Eluting Stent Sales Volume and Market Share by Type
6.3 Taiwan Coronary Drug-Eluting Stent Sales Volume and Market Share by Application

7 India Coronary Drug-Eluting Stent (Volume, Value and Sales Price)
7.1 India Coronary Drug-Eluting Stent Sales and Value (2012-2017)
7.1.1 India Coronary Drug-Eluting Stent Sales Volume and Growth Rate (2012-2017)
7.1.2 India Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2017)
7.1.3 India Coronary Drug-Eluting Stent Sales Price Trend (2012-2017)
7.2 India Coronary Drug-Eluting Stent Sales Volume and Market Share by Type
7.3 India Coronary Drug-Eluting Stent Sales Volume and Market Share by Application

8 Southeast Asia Coronary Drug-Eluting Stent (Volume, Value and Sales Price)
8.1 Southeast Asia Coronary Drug-Eluting Stent Sales and Value (2012-2017)
8.1.1 Southeast Asia Coronary Drug-Eluting Stent Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Coronary Drug-Eluting Stent Sales Price Trend (2012-2017)
8.2 Southeast Asia Coronary Drug-Eluting Stent Sales Volume and Market Share by Type
8.3 Southeast Asia Coronary Drug-Eluting Stent Sales Volume and Market Share by Application

9 Australia Coronary Drug-Eluting Stent (Volume, Value and Sales Price)
9.1 Australia Coronary Drug-Eluting Stent Sales and Value (2012-2017)
9.1.1 Australia Coronary Drug-Eluting Stent Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Coronary Drug-Eluting Stent Revenue and Growth Rate (2012-2017)
9.1.3 Australia Coronary Drug-Eluting Stent Sales Price Trend (2012-2017)
9.2 Australia Coronary Drug-Eluting Stent Sales Volume and Market Share by Type
9.3 Australia Coronary Drug-Eluting Stent Sales Volume and Market Share by Application

10 Asia-Pacific Coronary Drug-Eluting Stent Players/Suppliers Profiles and Sales Data
10.1 Boston Scientific
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Boston Scientific Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Cordis
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Cordis Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Abbott
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Abbott Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Advantec Vascular
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Advantec Vascular Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 B.Braun Melsengen AG
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 B.Braun Melsengen AG Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Biosensors
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Biosensors Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Biotronik
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Biotronik Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Blue Medical
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Blue Medical Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 DISA Vascular
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 DISA Vascular Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Essen
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Coronary Drug-Eluting Stent Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Essen Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Medtronic Vascular
10.12 MicroPort Medical
10.13 MIV Therapeutics
10.14 Orbusneich
10.15 Promed Medical
10.16 Relisys Medical
10.17 Reva Medical
10.18 Sahajanand
10.19 Sino Medical
10.20 Sorin
10.21 Terumo Medical
10.22 Translumina
10.23 Vascular Concepts
10.24 JW Medical Systems
10.25 Kinhely
10.26 Lepu Medical
10.27 Medfavour Medical

11 Coronary Drug-Eluting Stent Manufacturing Cost Analysis
11.1 Coronary Drug-Eluting Stent Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Coronary Drug-Eluting Stent

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Coronary Drug-Eluting Stent Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Coronary Drug-Eluting Stent Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Coronary Drug-Eluting Stent Market Forecast (2017-2022)
15.1 Asia-Pacific Coronary Drug-Eluting Stent Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Coronary Drug-Eluting Stent Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Coronary Drug-Eluting Stent Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Coronary Drug-Eluting Stent Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Coronary Drug-Eluting Stent Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Coronary Drug-Eluting Stent Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Coronary Drug-Eluting Stent Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Coronary Drug-Eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Coronary Drug-Eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Coronary Drug-Eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Coronary Drug-Eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Coronary Drug-Eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Coronary Drug-Eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Coronary Drug-Eluting Stent Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Coronary Drug-Eluting Stent Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Coronary Drug-Eluting Stent Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Coronary Drug-Eluting Stent Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Coronary Drug-Eluting Stent Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Coronary Drug-Eluting Stent Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer


Purchase this Market Research Report



Contact Us


Mannan
Mannan Shaikh
Domain Head
Business Development
+1 (650) 461-4455 (US)
mansing
Mansingh Surve
Manager
Business Development
+1 (888) 278-7681(US)
Vivek
Vivek Pandey
Assistant Manager
Business Development
+1 (888) 278-7681(US)
view